Skip to content
According to a new observational study, there is a possible association between exposure to aluminum adjuvants in childhood vaccines and the development of persistent […]
CDC advises no change for vaccines with aluminum adjuvants Read More »
What is worse than getting COVID-19? How about getting COVID-19 and the flu at the same time? That is precisely the concern that health
Vaccines are the best defense against co-circulation of flu and COVID Read More »
Today (October 10) is World Mental Health Day, on the heels of Mental Illness Awareness Week in the United States. This day is an
It’s World Mental Health Day – but mental health must be a priority every day Read More »
Shionogi, a pharmaceutical company headquartered in Japan, announced a licensing agreement on Tuesday that would contribute to making its COVID-19 therapeutic candidate accessible in
Shionogi shows how to share COVID-19 therapeutics while preserving IP Read More »
Pfizer Inc. announced on Wednesday it completed its nearly $5.4 billion acquisition of Global Blood Therapeutics, Inc. (GBT), the pioneer in treatments for sickle
Pfizer completes $5.4 billion acquisition of Global Blood Therapeutics Read More »
Vir Biotechnology Inc. has won a multi-year agreement with the U.S. government to support pandemic preparedness for influenza and other infectious disease threats, the
Vir Biotechnology gets government funding to address flu and future pandemics Read More »
With the COVID-19 pandemic still going strong, we were struck by the monkeypox outbreak in May, even though a vaccine existed. “Why weren’t we
Monkeypox outbreak: Did we learn anything to help us tackle the next threat? Read More »
Policymakers and public health leaders have been playing a dangerous game when it comes to how they are preparing, or rather are not preparing,
Shionogi shows how a biotech firm can tackle AMR Read More »
“Cancer’s resistance to treatments is the biggest challenge faced today in oncology, and this resistance is the cause of death from the disease,” said
OncoXome is charging ahead with gene therapy to treat resistant cancers Read More »
A subvariant of Omicron by the name of BA.2.75.2 is the most recent strain of COVID-19 causing concern. This variant has already developed the
New Omicron subvariant could create challenges this fall Read More »
